Similar articles for PMID: 26802180

Year	Number of Results
1988	1
1989	1
1991	1
1993	1
1994	1
1997	1
2001	1
2003	1
2004	1
2005	2
2006	3
2007	8
2008	9
2009	9
2010	6
2011	10
2012	7
2013	6
2014	11
2015	10
2016	13
2017	14
2018	8
2019	8
2020	10
2021	7
2022	3
2024	0

1

EULAR recommendations for the management of familial Mediterranean fever.

Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G, Ozdogan H, Abu I, Gattorno M, Hawkins PN, Yuce S, Kallinich T, Bilginer Y, Kastner D, Carmona L. Ozen S, et al. Ann Rheum Dis. 2016 Apr;75(4):644-51. doi: 10.1136/annrheumdis-2015-208690. Epub 2016 Jan 22. Ann Rheum Dis. 2016. PMID: 26802180 Free article.

2

Adherence to best practice consensus guidelines for familial Mediterranean fever: a modified Delphi study among paediatric rheumatologists in Turkey.

Kavrul Kayaalp G, Sozeri B, Sönmez HE, Demir F, Cakan M, Oztürk K, Karadag SG, Otar Yener G, Ozdel S, Baglan E, Celikel E, Sahin N, Gezgin Yildirim D, Eker Omeroglu R, Aktay Ayaz N; PeRA-Research Group. Kavrul Kayaalp G, et al. Rheumatol Int. 2022 Jan;42(1):87-94. doi: 10.1007/s00296-020-04776-1. Epub 2021 Jan 16. Rheumatol Int. 2022. PMID: 33454820 Free PMC article.

3

Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder.

Portincasa P, Scaccianoce G, Palasciano G. Portincasa P, et al. Eur J Clin Invest. 2013 Dec;43(12):1314-27. doi: 10.1111/eci.12170. Epub 2013 Oct 14. Eur J Clin Invest. 2013. PMID: 24117178 Review.

4

Defining colchicine resistance/intolerance in patients with familial Mediterranean fever: a modified-Delphi consensus approach.

Özen S, Sag E, Ben-Chetrit E, Gattorno M, Gül A, Hashkes PJ, Kone-Paut I, Lachmann HJ, Tsitsami E, Twilt M, Benedetti F, Kuemmerle-Deschner JB. Özen S, et al. Rheumatology (Oxford). 2021 Aug 2;60(8):3799-3808. doi: 10.1093/rheumatology/keaa863. Rheumatology (Oxford). 2021. PMID: 33331943

5

Familial Mediterranean fever.

Padeh S, Berkun Y. Padeh S, et al. Curr Opin Rheumatol. 2016 Sep;28(5):523-9. doi: 10.1097/BOR.0000000000000315. Curr Opin Rheumatol. 2016. PMID: 27286236 Review.

6

Approach to the patients with inadequate response to colchicine in familial Mediterranean fever.

Gül A. Gül A. Best Pract Res Clin Rheumatol. 2016 Apr;30(2):296-303. doi: 10.1016/j.berh.2016.09.001. Epub 2016 Sep 21. Best Pract Res Clin Rheumatol. 2016. PMID: 27886801 Review.

7

Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.

Eroglu FK, Beşbaş N, Topaloglu R, Ozen S. Eroglu FK, et al. Rheumatol Int. 2015 Oct;35(10):1733-7. doi: 10.1007/s00296-015-3293-2. Epub 2015 May 23. Rheumatol Int. 2015. PMID: 26001859

8

The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever.

Calligaris L, Marchetti F, Tommasini A, Ventura A. Calligaris L, et al. Eur J Pediatr. 2008 Jun;167(6):695-6. doi: 10.1007/s00431-007-0547-3. Epub 2007 Jun 23. Eur J Pediatr. 2008. PMID: 17588171 Free PMC article.

9

Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever.

Şahin A, Derin ME, Albayrak F, Karakaş B, Karagöz Y. Şahin A, et al. Adv Rheumatol. 2020 Jan 30;60(1):12. doi: 10.1186/s42358-020-0117-1. Adv Rheumatol. 2020. PMID: 32000860

10

Pearls from the Third Israeli Conference on FMF, other autoinflammatory disorders and AA amyloidosis.

Livneh A, Ben-Zvi I. Livneh A, et al. Isr Med Assoc J. 2014 May;16(5):269-70. Isr Med Assoc J. 2014. PMID: 24979827 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

122 results

Results by year